Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BLSH compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name
BLSH
Bullish
Change
Mkt cap
Revenue
Revenue
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BLSH
Bullish
vs
ARCT
Arcturus Therapeutics Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BLSH, solid
ARCT, dashed
Supply-chain overlap
Revenue flow
BLSH: latest quarter not drawable. ARCT: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BLSH
4
—
Deloitte & Touche LLP
unlisted
supplier
—
BitGo
unlisted
supplier
—
Fireblocks
unlisted
supplier
—
SPV KY
unlisted
supplier
Shared
0
No shared counterparties.
Only ARCT
3
—
Biomedical Advanced Research and Development Authority (BARDA)
unlisted
customer
—
CSL Seqirus
unlisted
customer
—
Meiji Seika Pharma
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BLSH
Bullish
Change
23.85
▼
−16.22%
· post 24.08
Mkt cap
$3.6B
Revenue
—
Revenue
—
ARCT
Arcturus Therapeutics Holdings Inc.
Change
11.01
▼
−9.38%
· post 11.01
Closed
Oct 30 '26
Mkt cap
$313.5M
Revenue
$3M
Q2 FY26
Revenue
$82M
FY25
vs
Compare
Closed
Oct 30 '26
BLSH
Bullish
vs
ARCT
Arcturus Therapeutics Holdings Inc.
23.85
▼
−16.22%
post 24.08
Price
11.01
▼
−9.38%
post 11.01
$3.6B
Mkt cap
$313.5M
—
Revenue
$3M
Q2 FY26
—
Revenue
$82M
FY25
Change
Change
BLSH
23.85
▼
−16.22%
vs
ARCT
11.01
▼
−9.38%
Closed
Oct 30 '26